Class IIITerminatedD-0107-2018
Drug recall · December 13, 2017
Isradapine Capsules USP 2.5 mg recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC 342806263013
- Lots / codes
Lot #: P0910-017, Exp. 05/2019
- Quantity
- 1264 bottles
- Company
- Elite Laboratories Inc., Northvale, NJ
- Distribution
- NY only
- Initiated
- November 13, 2017 · Voluntary: Firm initiated
- Classified
- December 5, 2017
- Reported
- December 13, 2017
- Ended
- March 15, 2019
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.